Related Experiment Video
Updated: Nov 16, 2025

09:45
Detection of Copy Number Alterations Using Single Cell Sequencing
Published on: February 17, 2017
11.9K
MEDALT: single-cell copy number lineage tracing enabling gene discovery
Fang Wang1,2, Qihan Wang1,3, Vakul Mohanty1
1Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX, USA.
Genome Biology
|February 24, 2021
Summary
We developed a new algorithm, MEDALT, to trace cell evolution using copy number data. This method accurately identifies cancer-driving genes and predicts survival in triple-negative breast cancer patients.
Area of Science:
- Computational Biology
- Genomics
- Cancer Research
Background:
- Understanding cancer evolution is crucial for developing effective treatments.
- Single-cell copy number (SCCN) profiles offer insights into cellular heterogeneity and evolution.
- Existing phylogenetic methods may have limitations in reconstructing copy number lineage.
Purpose of the Study:
- To introduce a novel algorithm, Minimal Event Distance Aneuploidy Lineage Tree (MEDALT), for inferring cell population evolution history from SCCN profiles.
- To present a statistical routine, lineage speciation analysis (LSA), for discovering fitness-associated alterations and genes from SCCN lineage trees.
- To validate the accuracy and utility of MEDALT and LSA in a triple-negative breast cancer (TNBC) cohort.
Main Methods:
- Development and application of the MEDALT algorithm for lineage reconstruction.
- Implementation of lineage speciation analysis (LSA) for identifying key genetic alterations.
- Analysis of SCCN data from 20 triple-negative breast cancer patients.
Main Results:
- MEDALT demonstrates higher accuracy in reconstructing copy number lineage compared to traditional phylogenetics approaches.
- LSA effectively prioritizes genes critical for breast cancer cell fitness.
- The study identified genes implicated in convergent evolution and their association with patient survival.
- The developed methods successfully predicted patient survival outcomes in the TNBC cohort.
Conclusions:
- MEDALT and LSA provide a powerful framework for analyzing cancer evolution from SCCN data.
- These computational tools can identify novel therapeutic targets and biomarkers for triple-negative breast cancer.
- The findings highlight the importance of convergent evolution in driving cancer progression and patient outcomes.

